Navigation Links
Vanda Pharmaceuticals Reports Third Quarter 2009 Results
Date:11/2/2009

o good faith discussions relating to the co-commercialization of Fanapt(TM) outside of the U.S. and Canada or, alternatively, Novartis will receive a royalty on net sales of Fanapt(TM) outside of the U.S. and Canada.

Vanda continued the clinical, regulatory and commercial evaluation for tasimelteon, a MT1/MT2 melatonin agonist, currently in Phase III stage of development.

FINANCIAL DETAILS

  • Operating Expenses. Third quarter 2009 R&D expenses of $2.1 million consisted primarily of $0.5 million of salaries and benefits, $0.7 million of non-cash stock based compensation costs for R&D personnel, $0.2 million for the carcinogenicity study and $0.2 million in consulting fees. This compares to $7.2 million for the second quarter of 2009 and $3.8 million for the third quarter of 2008. The decrease in R&D expenses in the third quarter of 2009 relative to the second quarter of 2009 is primarily due to the regulatory consulting fees accrued in the second quarter as a result of the approval of Fanapt(TM) by the FDA. The decrease in R&D expenses in the third quarter of 2009 relative to the third quarter of 2008 is primarily due to the completion of the Phase III clinical trial of tasimelteon in chronic primary insomnia in 2008.
  • General and administrative (G&A) expenses of $5.3 million for the third quarter of 2009 consisted primarily of $0.4 million of salaries and benefits and $2.6 million of non-cash stock based compensation costs for G&A personnel, as well as $0.5 million of legal fees, $0.7 million of commercial costs and $0.2 million of insurance costs. This compares to $5.0 million for the second quarter of 2009 and $7.4 million for the third quarter of 2008. The decrease in G&A expenses in the third quarter of 2009 relative to the third quarter of 2008 is primarily due to lower stock-based compensation and commercial expenses.
  • Empl
    '/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
2. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
3. Vanda Pharmaceuticals Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by Tang Capital
4. Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP
5. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
6. Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
7. Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
8. Vanda Pharmaceuticals Announces that it No Longer Intends to Offer Convertible Senior Notes
9. Vanda Pharmaceuticals VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties
10. Vanda Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 8, 2007
11. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 Thought Technology's ... of simple tools, designed to help clinicians do biofeedback ... no experience with biofeedback. The tools in the suite ... elucidate any abnormal patterns to teach them to recuperate ... world, we are familiar with stress and its negative ...
(Date:7/22/2014)... HIV researchers from Aarhus University and Aarhus University Hospital ... activate hidden HIV. The researchers found that the anti-cancer ... between 2.1 and 3.9 times above normal and that ... levels in five out of six patients with HIV ... were presented today as breaking news at the annual ...
(Date:7/22/2014)... the University of Murcia have studied the changes ... a personality trait that causes difficulties in inhibiting ... and leads to unplanned actions without considering the ... indicator for predicting the risk of behavioural problems. ... the University of Murcia analyses whether the connectivity ...
(Date:7/22/2014)... foreign vocabulary, our brains hold a seemingly endless ... older, our ability to learn and remember new ... Prof Dr Antonio Del Sol Mesa from the ... of Luxembourg and Dr Ronald van Kesteren of ... mechanisms of this cognitive decline using latest high-throughput ...
(Date:7/22/2014)... Expert Publishing (ExPub), a ... the launch of PoisonEXPERT™ , a resource ... employed by organizations that use or manufacture large ... impact of chemicals on their employees and the ... information and medical protocols that allows users to ...
Breaking Medicine News(10 mins):Health News:Thought Technology to Present Software for Stress Control at the 2014 American Psychological Association Convention in DC 2Health News:Thought Technology to Present Software for Stress Control at the 2014 American Psychological Association Convention in DC 3Health News:Anti-cancer drug kicks HIV out of hiding 2Health News:Children's impulsive behaviour is related to their brain connectivity 2Health News:Rigid connections: Molecular basis of age-related memory loss explained 2Health News:PoisonEXPERT™ from ExPub Now Available 2Health News:PoisonEXPERT™ from ExPub Now Available 3
... penis transplant, but were forced to remove it after the ... had lost his penis in an accident and was unable ... ,Doctors had attached a 10cm penis to the 44-year-old patient ... month's journal European Urology. 'Because of a severe psychological problem ...
... in Thiruvananthapuram said that there was no need to panic ... fever were reported in the city.// ,Health authorities said ... continue to pelt the state. The chikungunya scare so far ... not be confined to some pockets as mosquitoes are increasing ...
... for the treatment of mild to moderate obstructive ... The effectiveness of palatal implants for treatment of ... demonstrated in a number of clinical studies. Primarily, ... in apnea hypopnea index (AHI) as measured by ...
... cost the global economy up to $2 trillion or 4.8 ... said on Sunday.// ,In a worst-case scenario, 70 million ... the virus that had spread beyond East Asia to Europe, ... be the worst hit, with mortality rates double of those ...
... with now - a sharp rise in HIV/AIDS cases. While ... state, unofficial estimates peg the number at 25,000.// ... Features. The northern state lies in a low prevalence risk ... at 0.95 percent and among the low-risk groups at 0.06 ...
... be lost in several ways, not all may be healthy. ... is one of the healthy ways to lose weight.// ,The ... has found that eating high-fiber cereals not only help to ... magnesium and vitamin B-6. ,The study sponsored by Kraft, Dr. ...
Cached Medicine News:Health News:Palatal Implant Procedure Proven Effective in Eliminating Snoring 2Health News:Palatal Implant Procedure Proven Effective in Eliminating Snoring 3Health News:Kashmir Grapples with Growing AIDS 2Health News:Kashmir Grapples with Growing AIDS 3Health News:Weight Loss Healthier with a Diet of Whole Grain Cereals 2
(Date:7/22/2014)... MOUNTAIN VIEW, Calif. , July 22, 2014 ... magnetic resonance imaging (MRI) market, Frost & Sullivan ... Award for Product Leadership. Siemens Healthcare,s FREEZEit solution, ... addresses the need for robust and motion-insensitive imaging. ... has boosted the evolution of body MRI imaging ...
(Date:7/22/2014)... England , July 22, 2014 Elekta ... announced today that The Christie NHS Foundation Trust ( ... will join a consortium whose mission is to develop ... (MRI) guided radiation therapy system. Such a system would, ... visualization of cancer targets. "The Christie ...
(Date:7/22/2014)... Ariz. , July 22, 2014  A ... of a SynCardia temporary Total Artificial ... Rochester,s Strong Memorial Hospital with the Freedom® portable ... Fontana, a 64-year-old retiree from a ... decades. He managed the condition with medications, an ...
Breaking Medicine Technology:Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... FORD, Pa., March 29, 2012 Endo (Nasdaq: ENDP ... Bihl, will step down as head of the Endo devices operating ... successor, a comprehensive executive search has been initiated. Mr. ... acquisition of AMS and was named President and Chief Executive Officer ...
... VIEW, Calif., March 29, 2012  Based on its ... market, Frost & Sullivan recognizes Sensear with the ... Product Differentiation Excellence for its "high-noise communication" devices, ... products protect hearing while still enabling the user ...
Cached Medicine Technology:Endo Announces Departure of American Medical Systems President 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 3Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 4
... In certain hernia and soft tissue ... fascial defects, it is sometimes necessary ... one surface, while minimizing tissue attachment ... a soft, conformable, ePTFE sheet material ...
... Bard Dulex mesh is a dual-sided ePTFE ... side is a micro-porous structure designed to minimize ... side is a macro-porous structure designed to promote ... size of approximately 800 microns, which is nearly ...
... mesh is the first polypropylene mesh ... Visilex mesh directly addresses the critical ... specifically, it delivers maximum visibility, enhanced ... after insertion through the trocar.,Visilex mesh ...
... is constructed of knitted filaments of ... that used in PROLENE* Polypropylene Suture, ... The mesh is approximately,0.020 inches thick. ... suture, has been reported to be ...
Medicine Products: